第一作者单位:[1]Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Basic Med, Dept Pathogen Biol, 13 Hangkong Rd, Wuhan 430030, Hubei, Peoples R China
通讯作者:
通讯机构:[1]Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Basic Med, Dept Pathogen Biol, 13 Hangkong Rd, Wuhan 430030, Hubei, Peoples R China[2]Hubei Prov Ctr Dis Control & Prevent Hubei CDC, Inst Hlth Inspection & Testing, Wuhan 430079, Hubei, Peoples R China[3]Wuhan Univ, State Key Lab Virol, Wuhan 430071, Peoples R China[4]Wuhan Univ, Inst Med Virol, TaiKang Med Sch, Hubei Prov Key Lab Allergy & Immunol, Wuhan 430071, Peoples R China[5]Kangma Healthcode Shanghai Biotech Co Ltd, 118 Furonghua Rd,Bldg 15, Shanghai 201203, Peoples R China[6]Wuhan Univ, Inst Vaccine Res, Anim Biosafety LevelLaboratory Ctr Anim Expt 3, Sch Med, Wuhan 430071, Peoples R China[10]Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Pediat, Wuhan 430030, Hubei, Peoples R China
推荐引用方式(GB/T 7714):
Lv Panjing,Hu Bing,Hua Rong,et al.A novelly designed protein antagonist confers potent neutralization against SARS-CoV-2 variants of concern[J].JOURNAL OF INFECTION.2022,85(3):E72-E76.doi:10.1016/j.jinf.2022.06.001.
APA:
Lv, Panjing,Hu, Bing,Hua, Rong,Zhang, Jun,Zhang, Haoran...&Li, Yan.(2022).A novelly designed protein antagonist confers potent neutralization against SARS-CoV-2 variants of concern.JOURNAL OF INFECTION,85,(3)
MLA:
Lv, Panjing,et al."A novelly designed protein antagonist confers potent neutralization against SARS-CoV-2 variants of concern".JOURNAL OF INFECTION 85..3(2022):E72-E76